These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

73 related articles for article (PubMed ID: 4606478)

  • 21. [Collective studies on the administration of procainamide in the prevention of early mortality in myocardial infarct].
    Kardiol Pol; 1976; 19(4):317-24. PubMed ID: 787614
    [No Abstract]   [Full Text] [Related]  

  • 22. Lidocaine prophylaxis in myocardial infarction: a concept whose time has come.
    Wyman MG; Gore S
    Heart Lung; 1983 Jul; 12(4):358-61. PubMed ID: 6553037
    [No Abstract]   [Full Text] [Related]  

  • 23. Immediate primary care of a suspected heart attack.
    Drug Ther Bull; 1986 Nov; 24(23):89-91. PubMed ID: 3792212
    [No Abstract]   [Full Text] [Related]  

  • 24. Management of persistently recurring ventricular fibrillation with propranolol hydrochloride.
    Rothfeld EL; Lipowitz M; Zucker IR; Parsonnet V; Bernstein A
    JAMA; 1968 May; 204(6):546-8. PubMed ID: 5694440
    [No Abstract]   [Full Text] [Related]  

  • 25. Reevaluating the use of lidocaine.
    Nevins MA
    Geriatrics; 1973 Aug; 28(8):48-51. PubMed ID: 4605022
    [No Abstract]   [Full Text] [Related]  

  • 26. Prophylactic lidocaine in acute myocardial infarction: resurface or reburial?
    Yadav AV; Zipes DP
    Am J Cardiol; 2004 Sep; 94(5):606-8. PubMed ID: 15342291
    [No Abstract]   [Full Text] [Related]  

  • 27. Should prophylactic lidocaine be routinely used in patients suspected of acute myocardial infarction?
    Grauer K
    J Fla Med Assoc; 1982 May; 69(5):377-9. PubMed ID: 7097215
    [No Abstract]   [Full Text] [Related]  

  • 28. Prevention of primary ventricular fibrillation in acute myocardial infarction with prophylactic lidocaine.
    Wyman MG; Wyman RM; Cannom DS; Criley JM
    Am J Cardiol; 2004 Sep; 94(5):545-51. PubMed ID: 15342281
    [TBL] [Abstract][Full Text] [Related]  

  • 29. I.M. lidocaine injections for myocardial infarction.
    Felmers MC; Dunning AJ
    RN; 1975 Jul; 38(7):ICU6-7. PubMed ID: 1039795
    [No Abstract]   [Full Text] [Related]  

  • 30. Treatment with esmolol of ventricular fibrillation unresponsive to lidocaine and procainamide.
    van Dantzig JM; Koster RW; Biervliet JD
    J Cardiothorac Vasc Anesth; 1991 Dec; 5(6):600-3. PubMed ID: 1685101
    [No Abstract]   [Full Text] [Related]  

  • 31. Prognosis after recovery from ventricular fibrillation complicating ischaemic heart-disease.
    Geddes JS; Adgey AA; Pantridge JF
    Lancet; 1967 Aug; 2(7510):273-5. PubMed ID: 4165913
    [No Abstract]   [Full Text] [Related]  

  • 32. Prehospital care of acute myocardial infarction.
    Yu PN
    Circulation; 1972 Jan; 45(1):189-204. PubMed ID: 4108658
    [No Abstract]   [Full Text] [Related]  

  • 33. [Effect of previous administration of amiodarone on the early incidence of ventricular fibrillation during experimental myocardial ischemia].
    Spadaro J; Hashimoto LM; Franco RS; Bregagnollo EA; Tucci PJ
    Arq Bras Cardiol; 1984 Jan; 42(1):25-9. PubMed ID: 6743037
    [No Abstract]   [Full Text] [Related]  

  • 34. [Effects of sulfinpyrazone on early ventricular fibrillation and 2d-phase arrhythmias in acute myocardial infarction (author's transl)].
    Gülker H; Bender F; Thale J; Heuer H; Kristek J; Dorsel T; Pierchalla P
    Z Kardiol; 1980 Nov; 69(11):751-6. PubMed ID: 7467658
    [TBL] [Abstract][Full Text] [Related]  

  • 35. [The importance of premonitory arrhythmias of primary ventricular fibrillation (PVF) in myocardial infarct].
    Leone A; Duce T
    Boll Soc Ital Cardiol; 1981; 26(12):2205-8. PubMed ID: 7185389
    [No Abstract]   [Full Text] [Related]  

  • 36. Should prophylactic antiarrhythmic drug therapy be employed in acute myocardial infarction?
    Berte LE; Harrison DC
    Cardiovasc Clin; 1983; 13(1):173-81. PubMed ID: 6336666
    [No Abstract]   [Full Text] [Related]  

  • 37. Pharmacological investigation of a new orally active antiarrhythmic drug Su-13197.
    Barrett WE; Garces T; Plummer AJ
    Arch Int Pharmacodyn Ther; 1969 Nov; 182(1):65-77. PubMed ID: 5365241
    [No Abstract]   [Full Text] [Related]  

  • 38. Epicardial, endocardial and transmural mapping in assessing electrophysiological effects of 14-C lidocaine and 14-C propafenone on activation times in experimental chronic myocardial infarction. Correlations with myocardial drugs concentrations.
    Naccarella FF; Agarwal JB; Weintraub WS; Bracchetti D; Helfant RH
    G Ital Cardiol; 1984 Oct; 14(10):825-9. PubMed ID: 6519392
    [TBL] [Abstract][Full Text] [Related]  

  • 39. [The treatment of ventricular arrhythmias caused by myocardial infarct with xylocaine. Importance to recourse of electrosystolic pacing].
    Bernard R; Stacquez A; Thys JP; Cornil A
    Mal Cardiovasc; 1969; 10(4):827-39. PubMed ID: 5405790
    [No Abstract]   [Full Text] [Related]  

  • 40. [Result report of a control by an apparatus of 208 myocardial infarct patients in an intensive care station. Preliminary report].
    Herbinger W
    Wien Med Wochenschr; 1971 Jun; 121(25):518-22. PubMed ID: 5129947
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 4.